Psychosocial Factors Affecting Glycemic Control in Children and Adolescents With Type 1 Diabetes Mellitus
Psychosocial and Socioeconomic Factors Affecting Glycemic Control in Children and Adolescents With Type 1 Diabetes Mellitus
1 other identifier
observational
191
1 country
1
Brief Summary
The aim of the study is to research psychosocial and socioeconomic factors among families that might affect glycemic control in children and adolescent with type 1 diabetes mellitus. These factors might be: living conditions, structure of the family, socioeconomic status, divorces and parent's own glycemic control status (if parent's type 1 diabetes mellitus is present in the family).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 15, 2019
CompletedFirst Posted
Study publicly available on registry
December 4, 2019
CompletedStudy Start
First participant enrolled
November 3, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2021
CompletedMay 17, 2022
May 1, 2022
1.2 years
November 15, 2019
May 16, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Children's type 1 diabetes glycemic control
Socioeconomic and psychosocial factors affecting in type 1 diabetes glycemic status in children
Through study completion, an average 5 years
Secondary Outcomes (2)
Parents' divorce rate
Through study completion, an average 5 years
Parent's type 1 diabetes glycemic status
Through study completion, an average 5 years
Study Arms (1)
Diabetic children aged 1-16 years and their families
Diabetic children aged 1-16 years and their families. A child's disease duration must be over 1 year so that possible remission period is over.
Eligibility Criteria
Type 1 diabetic children aged 1-16 years followed at Tampere University Hospital and their parents . Child's disease duration minimum 1 year.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tampere University Hospital
Tampere, 33100, Finland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marja-Terttu Saha
Tampere University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 15, 2019
First Posted
December 4, 2019
Study Start
November 3, 2020
Primary Completion
December 30, 2021
Study Completion
December 30, 2021
Last Updated
May 17, 2022
Record last verified: 2022-05